bloom glp 1 Frontiers Targeting GLP-1 receptor trafficking to
Description
Advances in diabetes technology within the digital diabetes ecosystem
Compared with white patients, all other ethnic groups had significantly decreased odds of SGLT2 inhibitors and GLP-1 receptor agonists prescriptions after accounting for patient- and system-level factors
Other options include hydroxychloroquine, sulfasalazine, and leflunomide
Diabetol Metab Syndr 17(1):315 McCrimmon RJ, Catarig AM, Frias JP, Lausvig NL, le Roux CW, Thielke D et al (2020) Effects of once-weekly semaglutide vs once-daily Canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
Potential customers should also be able to verify that a pharmacy is licensed, since these are public records available online in most states
